Prediction of therapeutic response in acute treatment with antidepressants

Results of an empirical study involving 159 endogenous depressive inpatients
  • H. J. Möller
  • G. Fischer
  • D. v. Zerssen
Article
Received:

Summary

A study was carried out involving 159 endogenous depressive inpatients treated with antidepressants. Using standardized rating instruments, a large set of potential predictor variables was tested. After cross-validation according to the split-half technique, only very few of these proved to be suitable as predictors for the main outcome criteria. These predictors included premorbid maladjustment, neurotic traits of premorbid personality, intensity of depressive-apathetic symptoms at admission, and the self-evaluated mood assessment score 3 weeks after commencement of treatment. This last criterion demonstrated the highest predictive value. Several predictors known from the literature could not be reproduced in this study.

Key words

Endogenous depression Therapy with antidepressants Prediction of response to antidepressants 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ananth J (1978) Clinical prediction of antidepressant response. Int Pharmacopsychiatr 13:69–93Google Scholar
  2. Angst J (1961) A clinical analysis of the effects of Tofranil in depression. Longitudinal and follow-up studies. Treatment of blood relations. Psychopharmakologia 2:381–407Google Scholar
  3. Angst J (1965) Zur Prognose antidepressiver Behandlungen. Anglo-Germ Med Rev 2:733–751Google Scholar
  4. Barthelmes H, Zerssen D v (1978) Das Münchner psychiatrische Informationssystem (PSYCHIS München). In: Reichertz P, Schwarz E (Hrsg) Informationssysteme in der medizinischen Versorgung, Ökologie der Systeme. Schattauer, Stuttgart, pp 138–145Google Scholar
  5. Beckmann H (1978) Biochemische Grundlagen der engogenen Depression. Nervenarzt 49:557–568Google Scholar
  6. Beckmann H (1981) Die medikamentöse Therapie der Depressionen. Nervenarzt 52:135–146Google Scholar
  7. Bielski RJ, Friedel O (1976) Prediction of tricyclic antidepressant response. A critical review. Arch Gen Psychiatry 33:1479–1489Google Scholar
  8. Brengelmann JC, Brengelmann L (1960) Deutsche Validierung von Fragebögen der Extraversion, neurotischen Tendenz und Rigidität. Z Exp Angew Psychol 7:291–331Google Scholar
  9. Cording-Tömmel C, Zerssen D v (1982) Mianserin and Maprotilin as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinic evaluation of the efficacy of antidepressants. Pharmacopsychiatry 15:197–204Google Scholar
  10. Deykin EY, DiMascio A (1972) Relationship of patient background characteristics to efficacy of pharmacotherapy in depression. J Nerv Ment Dis 155:209–215Google Scholar
  11. Downing RW, Rickels K (1972) Predictors of amitriptyline response in outpatient depressives. J Nerv Ment Dis 154:248–263Google Scholar
  12. Downing RW, Rickels K (1973) Predictors of response to amitriptyline and placebo in three outpatient treatment settings. J Nerv Ment Dis 156:109–129Google Scholar
  13. Fähndrich E (1983) Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients. Pharmacopsychiatry 16:179–185Google Scholar
  14. Gaertner HJ, Kreuter F, Scharek G, Golfinopoulos G, Breyer-Pfaff U (1982) Zur klinischen Bedeutung einer biochemischen Differenzierung bei depressiven Erkrankungen. In: Beckmann H (Hrsg) Biologische Psychiatrie. Fortschritte psychiatrischer Forschung. Thieme, Stuttgart New York, pp 259–270Google Scholar
  15. Giedke H, Axmann D, Gaertner HJ, Rein W, Rötzer-Zimmer FT (1986) Psychopathological predictors of antidepressant therapy response. Pharmacopsychatry 19:259–262Google Scholar
  16. Gittelmann-Klein R, Klein D (1969) Premorbid asocial adjustment and prognosis in schizophrenia. J Psychiatr Res 7:35–53Google Scholar
  17. Greden Jf, Gaerner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression test in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 40:493Google Scholar
  18. Guy W (1976) Clinical Global Impressions (CGI). ECDEU Assessment, manual for psychopharmacology, rev edn. Rockville, Maryland, pp 217–222Google Scholar
  19. Harris JG (1975) An abbreviated form of the Phillips Rating Scale of premorbid adjustment in schizophrenia. J Abnorm Psychol 84:129–137Google Scholar
  20. Heimann H (1974) Therapy-resistant depressions: Symptoms and syndromes. Contributions to symptomatology and syndromes. Pharmakopsychiatr 7:139–144Google Scholar
  21. Helmchen H (1974) Symptomatology of therapy-resistant depressions. Pharmakopsychiatr 7:145–155Google Scholar
  22. Hollister LE, Overall JE, Johnson M, Penninton V, Katz G, Shelton J (1964) Controlled comparison of amitriptyline, imipramine and placebo in hospitalized depressed patients. J Nerv Ment Dis 139:370–375Google Scholar
  23. Hordern A, Holt NF, Burt CG, Gordon WF (1963) Amitriptyline in depressive states. Phenomenology and prognostic considerations. Br J Psychiatry 109:815–825Google Scholar
  24. Huber G, Gross G, Schüttler R (1979) Schizophrenie. Eine verlaufsund sozialpsychiatrische Langzeitstudie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  25. Kiloh LG, Ball JR, Garside RF (1962) Prognostic factors in treatment of depressive states with imipramine.Br Med J 2:1225–1227Google Scholar
  26. Klerman GL, Cole JO (1965) Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 17:101–141Google Scholar
  27. Kupfer DJ, Spiker DG (1981) Refractory depression: Prediction of non-response by clinical indicators. J Clin Psychiatry 42:307–311Google Scholar
  28. Lehmann HE (1974) Therapy-resistant depressions — a clinical classification. Pharmakopsychiatry 7:156–163Google Scholar
  29. Lesse S (1960) The evaluation of imipramine hydrochloride in the ambulatory treatment of depressed patients. J Neuropsychiatry 1:246–252Google Scholar
  30. Levine J, Raskin A (1974) Predicting treatment responsiveness-resistivness in a population of depressed patients. Pharmakopsychiatry 7:217–222Google Scholar
  31. Lorr M (1974) Assessing psychotic behavior by the IMPS. In: Pichot P, Olivier R (eds) Psychological measurement in psychopharmacology. Modem problems in pharmacopsychiatry. Karger, BaselGoogle Scholar
  32. Möller HJ (1985) Kontrollierte Untersuchungen zum Wirkungsnachweis von Amitriptylin unter besonderer Berücksichtigung des Stellenwertes von Amitriptylin gegenüber den neuen Antidepressiva. Literaturübersicht und Analyse methodischer Probleme. In: Beckmann H, Sieberns (Hrsg) Das ärztliche Gespräch. 38. pmi Verlag, Frankfurt, pp 135–147Google Scholar
  33. Möller HJ, Barthelmes H, Zerssen D von (1983) Forschungsmöglichkeiten auf der Grundlage einer routinemäßig durchgeführten Basis- und Befunddokumentation. Psychiatria Clin 16:1–16Google Scholar
  34. Möller HJ, Kissling W, Bottermann P (1986) the dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions. Eur Arch Psychiatr Neurol Sci 235:263–268Google Scholar
  35. Moore H, Kleining G (1960) Das soziale Selbstbild der Gesellschaftsschichten in Deutschland. Kölner Z Soziol Sozialpsychol 12:86Google Scholar
  36. Morris JB, Beck AT (1974) The efficacy of antidepressant drugs. A review of research (1958–1972). Arch Gen Psychiatry 30:667–674Google Scholar
  37. Paykel ES, Prusoff BA, Klerman GI, Haskell D, DiMascio A (1973) Clinical responses to amitriptyline among depressed women. J Nerv Ment Dis 156:149–165Google Scholar
  38. Philipp M, Beck V, Glocke M, Metz K, Scherhag R, Schmidt R (1985) Vorhersagbarkeit des Therapieansprechens depressiver Patienten auf Doxepin. In: Philipp M (Hrsg) Grundlagen und Erfolgsvorhersage der ambulanten Therapie mit Antidepressiva. Springer, Berlin Heidelberg New York Tokyo, pp 29–45Google Scholar
  39. Raskin A, Crook TH (1976) The endogenous-neurotic distinction as a predictor of response to antidepressant drugs. Psychol Med 6:59Google Scholar
  40. Report to Medical Research Council by its Clinical Psychiatry Committee (1965) Clinical trial of the treatment of depressive illness. Br Med J 1:881Google Scholar
  41. Sandifer MG, Wilson IC, Gambill JM (1965) The influence of case selection and dosage in an antidepressant drug trial. Br J Psychiatry 111:142–148Google Scholar
  42. Strauss JS, Carpenter WT (1974) Prediction of outcome in schizophrenia. II: Relationship between predictor and outcome variables. Arch Gen Psychiatry 31:37–42Google Scholar
  43. Wechsler D (1964) Die Messung der Intelligenz Erwachsener. Huber, Bern Stuttgart WienGoogle Scholar
  44. Woggon B (1980) Veränderungen der psychopathologischen Symptomatik während 20tägiger antidepressiver oder neuroleptischer Behandlung. Psychiatria Clin 13:150–164Google Scholar
  45. Woggon B (1983) Prognose der Pharmakotherapie. Klinische Untersuchung zur Voraussagbarkeit des Kurzzeittherapierfolges von Neuroleptika und Antidepressiva. Forum der Psychiatrie 16, Enke, StuttgartGoogle Scholar
  46. Zerssen D von (1979) Klinisch-psychiatrische Selbstbeurteilungs-Fragebögen. In: Baumann U, Berbalk H, Seidenstücker G (Hrsg) Klinische Psychologie. Trends in Forschung und Praxis, Bd II. Huber, BernGoogle Scholar
  47. Zerssen D von (1980) Psychopathometrische Verfahrcn und ihre Anwendung in der Psychiatric. In: Peters (Hrsg) Psychologie des 20. Jahrhunderts, Bd X. Kindler, ZurichGoogle Scholar
  48. Zerssen D von (1982) Personality and affective disorders. In: Paykel ES (ed) Handbook of affective disorders. Churchill Livingston, Edinburgh London Melbourne New York, pp 212–228Google Scholar
  49. Zerssen D von (1986) Clinical self-rating scales (CSRS) of the Munich psychiatric information system (PSYCHIS München). In: Sartorius N, Ban TA (eds) Assessment of depression. Springer, Berlin Heidelberg New York, pp 270–303Google Scholar
  50. Zerssen D von, Cording C (1978) The measurement of change in endogenous affective disorders. Arch Psychiatr Nervenkr 226:95–112Google Scholar
  51. Zerssen D von, Koeller D-M (1976) Klinische Selbstbeurteilungs-Skalen (KSb-S) aus dem Münchener Psychiatrischen Informationssystem (PSYCHIS München). Manuale. a) Allgemeiner Teil; b) Beschwerden-Liste; c) Paranoid-Depressivitäts-Skala; d) Befindlichkeits-Skala. Beltz-Test, WeinheimGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • H. J. Möller
    • 1
  • G. Fischer
    • 1
  • D. v. Zerssen
    • 1
  1. 1.The Max-Planck Institute for Psychiatry, Munichin collaboration with the Psychiatric Clinic of the Technical University MunichGermany

Personalised recommendations